Why NeuroPace, Inc.’s (NPCE) Stock Is Up 7.80%
As of Monday, November 16, NeuroPace, Inc.’s NPCE share price has surged by 7.80%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Tudor Pop
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | NPCE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $274.8 | $380.3 | 32% |
|
| Shares Out (Mil) | 34.3 | 41.2 | 39% |
|
| Institutional Ownership | 94.5% | 84.0% | 65% |
|
| Float (Mil) | 25.7 | 35.2 | 33% |
|
| Beta | 1.93 | 0.85 | 91% |
|
| Avg Daily Volume (000s) | 917 | 341 | 67% |
|
| Price Change (52-week) |
(37.7%) | 59.6% | 26% |
|
| Growth | NPCE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 19.5% | 11.8% | 81% |
|
| Net Income (5yr) | 2.4% | (5.6%) | 43% |
|
| EPS (5yr) | 64.6% | 10.6% | 97 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (70.4%) | (16.0%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 9 | |
| Current EPS | ($0.150) | ($0.452) | ($0.408) | |
| Month Ago EPS | ($0.067) | ($0.407) | ($0.191) | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | ($0.068) | ($0.415) | ($0.192) | |
| Year/Year Chg | 56.3% | (31.1%) | (74.5%) | |
| Financials | NPCE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $107 | $127 | 26% |
|
| Net Income (TTM) (Mil) | ($19) | ($9) | 24% |
|
| EPS (TTM) | ($0.558) | ($0.300) | 26% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | ($1) | 19% |
|
| Net Cash Flow (TTM) (Mil) | ($10) | $2 | 32% |
|
| Long-Term Debt (Q1) (Mil) | $67 | $25 | 41% |
|
| Enterprise Value (Q1) (Mil) | $281 | $400 | 29% |
|
| Valuation | NPCE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 24.17 | 2.62 | 97% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | NPCE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.8% | 59.1% | 87% |
|
| Net Margin | (17.7%) | (4.5%) | 17% |
|
| ROA | (18.7%) | (11.0%) | 20% |
|
| ROE | (126.1%) | (8.5%) | 7% |
|
| Liabilities to Assets | 87.9% | 45.9% | 82% |
|
| F-Score | 5 | 4 | 50% |
|
NeuroPace, Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors